NCT07017179 - This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/Overweight | Biotech Hunter

Enrollment

871

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

August 6, 2026

Study Completion Date

August 6, 2026

Conditions

Obesity/Overweight

Interventions

DRUG

AZD6234

Participants will receive a subcutaneous injection weekly

DRUG

Placebo

Participants will receive a subcutaneous injection weekly.

DRUG

AZD9550

Participants will receive a subcutaneous injection weekly

DRUG

Plocebo

Participants will receive a subcutaneous injection weekly

DRUG

AZD6234 in combination with AZD9550

Participants will receive a subcutaneous injection weekly

DRUG

Placebo

Participants will receive a subcutaneous injection weekly

Trial Locations (3)

RECRUITING

Research Site, Shanghai

RECRUITING

Research Site, Nanjing

RECRUITING

Research Site, Jinan